table of content
1 Study Coverage
1.1 Short Bowel Syndrome(SBS) Drugs Product Introduction
1.2 Global Short Bowel Syndrome(SBS) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Short Bowel Syndrome(SBS) Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume for the Year 2017-2028
1.3 United States Short Bowel Syndrome(SBS) Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Short Bowel Syndrome(SBS) Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Short Bowel Syndrome(SBS) Drugs Sales in Volume for the Year 2017-2028
1.4 Short Bowel Syndrome(SBS) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Short Bowel Syndrome(SBS) Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Short Bowel Syndrome(SBS) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Short Bowel Syndrome(SBS) Drugs Market Dynamics
1.5.1 Short Bowel Syndrome(SBS) Drugs Industry Trends
1.5.2 Short Bowel Syndrome(SBS) Drugs Market Drivers
1.5.3 Short Bowel Syndrome(SBS) Drugs Market Challenges
1.5.4 Short Bowel Syndrome(SBS) Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Short Bowel Syndrome(SBS) Drugs Market Segment by Type
2.1.1 Glucagon-Like Peptide-2(GLP-2)
2.1.2 Growth Hormone
2.1.3 Glutamine
2.1.4 Other
2.2 Global Short Bowel Syndrome(SBS) Drugs Market Size by Type
2.2.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Short Bowel Syndrome(SBS) Drugs Market Size by Type
2.3.1 United States Short Bowel Syndrome(SBS) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Short Bowel Syndrome(SBS) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Sale Channel
3.1 Short Bowel Syndrome(SBS) Drugs Market Segment by Sale Channel
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Retail Pharmacies
3.2 Global Short Bowel Syndrome(SBS) Drugs Market Size by Sale Channel
3.2.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Value, by Sale Channel (2017, 2022 & 2028)
3.2.2 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume, by Sale Channel (2017, 2022 & 2028)
3.3.3 Global Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) by Sale Channel (2017, 2022 & 2028)
3.3 United States Short Bowel Syndrome(SBS) Drugs Market Size by Sale Channel
3.3.1 United States Short Bowel Syndrome(SBS) Drugs Sales in Value, by Sale Channel (2017, 2022 & 2028)
3.3.2 United States Short Bowel Syndrome(SBS) Drugs Sales in Volume, by Sale Channel (2017, 2022 & 2028)
3.3.3 United States Short Bowel Syndrome(SBS) Drugs Average Selling Price (ASP) by Sale Channel (2017, 2022 & 2028)
4 Global Short Bowel Syndrome(SBS) Drugs Competitor Landscape by Company
4.1 Global Short Bowel Syndrome(SBS) Drugs Market Size by Company
4.1.1 Top Global Short Bowel Syndrome(SBS) Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Short Bowel Syndrome(SBS) Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Short Bowel Syndrome(SBS) Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Short Bowel Syndrome(SBS) Drugs Price by Manufacturer (2017-2022)
4.2 Global Short Bowel Syndrome(SBS) Drugs Concentration Ratio (CR)
4.2.1 Short Bowel Syndrome(SBS) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Short Bowel Syndrome(SBS) Drugs in 2021
4.2.3 Global Short Bowel Syndrome(SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Short Bowel Syndrome(SBS) Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Short Bowel Syndrome(SBS) Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Short Bowel Syndrome(SBS) Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Short Bowel Syndrome(SBS) Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Short Bowel Syndrome(SBS) Drugs Market Size by Company
4.5.1 Top Short Bowel Syndrome(SBS) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Short Bowel Syndrome(SBS) Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Short Bowel Syndrome(SBS) Drugs Sales by Players (2020, 2021 & 2022)
5 Global Short Bowel Syndrome(SBS) Drugs Market Size by Region
5.1 Global Short Bowel Syndrome(SBS) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Short Bowel Syndrome(SBS) Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Short Bowel Syndrome(SBS) Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Short Bowel Syndrome(SBS) Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Short Bowel Syndrome(SBS) Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Short Bowel Syndrome(SBS) Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Short Bowel Syndrome(SBS) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Merck
7.1.1 Merck Corporation Information
7.1.2 Merck Description and Business Overview
7.1.3 Merck Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck Short Bowel Syndrome(SBS) Drugs Products Offered
7.1.5 Merck Recent Development
7.2 Takeda
7.2.1 Takeda Corporation Information
7.2.2 Takeda Description and Business Overview
7.2.3 Takeda Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Takeda Short Bowel Syndrome(SBS) Drugs Products Offered
7.2.5 Takeda Recent Development
7.3 Emmaus Medical
7.3.1 Emmaus Medical Corporation Information
7.3.2 Emmaus Medical Description and Business Overview
7.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Products Offered
7.3.5 Emmaus Medical Recent Development
7.4 Ardelyx
7.4.1 Ardelyx Corporation Information
7.4.2 Ardelyx Description and Business Overview
7.4.3 Ardelyx Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ardelyx Short Bowel Syndrome(SBS) Drugs Products Offered
7.4.5 Ardelyx Recent Development
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Corporation Information
7.5.2 Naia Pharmaceuticals Description and Business Overview
7.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Products Offered
7.5.5 Naia Pharmaceuticals Recent Development
7.6 Nutrinia
7.6.1 Nutrinia Corporation Information
7.6.2 Nutrinia Description and Business Overview
7.6.3 Nutrinia Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Nutrinia Short Bowel Syndrome(SBS) Drugs Products Offered
7.6.5 Nutrinia Recent Development
7.7 OxThera
7.7.1 OxThera Corporation Information
7.7.2 OxThera Description and Business Overview
7.7.3 OxThera Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 OxThera Short Bowel Syndrome(SBS) Drugs Products Offered
7.7.5 OxThera Recent Development
7.8 Sancilio Pharmaceuticals
7.8.1 Sancilio Pharmaceuticals Corporation Information
7.8.2 Sancilio Pharmaceuticals Description and Business Overview
7.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Products Offered
7.8.5 Sancilio Pharmaceuticals Recent Development
7.9 Zealand Pharma
7.9.1 Zealand Pharma Corporation Information
7.9.2 Zealand Pharma Description and Business Overview
7.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Products Offered
7.9.5 Zealand Pharma Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Short Bowel Syndrome(SBS) Drugs Industry Chain Analysis
8.2 Short Bowel Syndrome(SBS) Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Short Bowel Syndrome(SBS) Drugs Distributors
8.3 Short Bowel Syndrome(SBS) Drugs Production Mode & Process
8.4 Short Bowel Syndrome(SBS) Drugs Sales and Marketing
8.4.1 Short Bowel Syndrome(SBS) Drugs Sales Channels
8.4.2 Short Bowel Syndrome(SBS) Drugs Distributors
8.5 Short Bowel Syndrome(SBS) Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
